62332-0311 Bosutinib - CanMED: NDC

Return Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

62332-0311

Brand Name:

Bosutinib

Generic Name:

Bosutinib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: BOSUTINIB

Strength: 100.0

Unit: mg/1

Packages:

Code: 62332-0311-35

Description: 120 TABLET, FILM COATED in 1 BOTTLE (62332-311-35)

Effective Date: May 19, 2026

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

BCR-ABL

Orphan Drug Designation:

Status:

In Use